ARCHIVES

DCT Advisors OK Recompetition Of Drug Contacts

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

FDA Expands Gleevec Indication For Children with Ph+ ALL

January 25, 2013

In Brief: New Contract To Speed Drug Development Planned; Groups To Get $5.6 Million Extra

February 27, 1976

Sole Source Negotiations

March 7, 1975

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

Techniques Developing Out Of Virus research Leading To Improved Therapy, Early Diagnosis

March 4, 1977

Coordination, Funding Lacking In National Cancer Program: Report

October 7, 1994